This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Messinis, I. E. Articles by Templeton, A. A. Search for Related Content PubMed Articles by Messinis, I. E. Articles by Templeton, A. A.

Effect of an increase in FSH on the production of gonadotrophin-surge-attenuating factor in women

Gonadotrophin-surge-attenuating factor (GnSAF) is a putative nonsteroidal ovarian factor that is produced by FSH and that attenuates the LH surge in superovulated women. To study further the role of FSH in the production of GnSAF, 12 normally ovulating women were divided into two groups and investigated during two cycles: a cycle treated with placebo (control) and a cycle treated with FSH. In group 1 (n = 6), placebo (2 ml 0.9% normal saline) or FSH (450 iu) was injected i.m. on day 2 of the cycle (09:00 h). In group 2 (n = 6), placebo (2 ml 0.9% normal saline) or FSH (225 iu) was injected on the day (09:00 h) on which the dominant follicle was 14–15 mm in diameter, as measured by ultrasound (i.e. after the pituitary had been primed by endogenous oestrogen for several days). The response of LH over 30 min (ALH) to an injection of 10 µg LHRH i.v. (bioassay for GnSAF in vivo) was investigated once a day in group 1, and 4, 8, 12 and 24 h after the injection of placebo or FSH in group 2. In group 1, ALH was significantly attenuated 12 h after treatment with FSH compared with the control cycles, while serum oestradiol concentrations increased 24 h after the injection of FSH. The decrease in ALH lasted for the period when the FSH concentation was increased (3 days). A significant decrease in the basal concentration of LH was correlated with the increase in the oestradiol concentration. In group 2, ALH increased significantly between 4 and 8 h after treatment (LHRH self-priming effect) in both cycles. However, ALH was significantly attenuated in the FSH-treated cycles compared with the control cycles after 8, 12 and 24 h. At the same time, serum concentrations of oestradiol and immunoreactive inhibin did not change significantly. These results suggest that GnSAF is a nonsteroidal ovarian substance, different from inhibin, the production of which is dependent on FSH and which exerts potent antagonistic effects on the oestradiol-induced self-priming action of LHRH.

This article has been cited by other articles:

				I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]

				E. Karligiotou, P. Kollia, A. Kallitsaris, and I.E. Messinis Expression of human serum albumin (HSA) mRNA in human granulosa cells: potential correlation of the 95 amino acid long carboxyl terminal of HSA to gonadotrophin surge-attenuating factor Hum. Reprod., March 1, 2006; 21(3): 645 - 650. [Abstract] [Full Text] [PDF]

				K. Dafopoulos, C.G. Kotsovassilis, S. Milingos, A. Kallitsaris, G. Galazios, E. Zintzaras, P. Sotiros, and I.E. Messinis Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role Hum. Reprod., September 1, 2004; 19(9): 1985 - 1992. [Abstract] [Full Text] [PDF]

				P. A. Fowler, T. Sorsa-Leslie, P. Cash, B. Dunbar, W. Melvin, Y. Wilson, H. D. Mason, and W. Harris A 60-66 kDa protein with gonadotrophin surge attenuating factor bioactivity is produced by human ovarian granulosa cells Mol. Hum. Reprod., September 1, 2002; 8(9): 823 - 832. [Abstract] [Full Text] [PDF]

				P. A. Fowler, T. Sorsa, W. J. Harris, P. G. Knight, and H. D. Mason Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women Hum. Reprod., July 1, 2001; 16(7): 1353 - 1358. [Abstract] [Full Text] [PDF]